You can access any of the podium or poster presentations’ abstracts by searching for it below. For the 2026 FIP world congress in Montreal, presentations and summaries from invited speakers are available below, while abstracts are published in the Pharmacy Education Journal (PEJ) here.
Export this Abstract | Print this Abstract |
Add to my preferred Abstracts list |
My preferred Abstracts list (18) |
Back to Search
Integrated physiologically based pharmacokinetic modeling for dibutyl phthalate and benzyl butyl phthalate and their active metabolites, mono butyl phthalate and mono benzyl phthalate, in rats
- In: Poster presentation
- At: Seoul (South Korea) (2017)
- Type: Poster
- Poster code: POS-PAA-014
- By: PARK, Junwoo (sungkyunkwan university, suwon, Korea, Republic Of)
- Co-author(s): Junwoo Park: School of Pharmacy, Sungkyunkwan University, Suwon, Korea, Republic Of
Tae Hwan Kim: School of Pharmacy, Sungkyunkwan University, Suwon, Korea, Republic Of
Min Gi Kim: School of Pharmacy, Sungkyunkwan University, Suwon, Korea, Republic Of
Sungwook Park: School of Pharmacy, Sungkyunkwan University, Suwon, Korea, Republic Of
Beom Soo Shin: College of Pharmacy, Catholic Univerity of Daegu, Gyeongsan, Korea, Republic Of
Sun Dong Yoo: School of Pharmacy, Sungkyunkwan University, Suwon, Korea, Republic Of - Abstract:
Background
Dibutyl phthalate (DBP) and benzyl butyl phthalate (BBP) are the plasticizers commonly used to increase the flexibility of PVCs. When orally exposed, DBP and BBP are metabolized in the gut to mono butyl phthalate (MBuP) and mono benzyl phthalate (MBzP). DBP and BBP are classified as the developmental toxicants and their metabolites are.. The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress.
Please login
Last update 23 September 2026